Mone F, et al. - Researchers performed a multicentre open-label feasibility randomised controlled trial to assess the feasibility and acceptability of routine aspirin in low-risk women, compared with screening-test indicated aspirin for the prevention of pre-eclampsia and fetal growth restriction. Participants in the investigation were 546 low-risk nulliparous women who completed the study. It was observed that low-risk nulliparous women were open to taking aspirin in pregnancy and had high levels of adherence. They found that aspirin use was correlated with greater rates of vaginal bleeding.